Stephen Thau is a corporate partner whose practice focuses on the representation of life science, medical device, health IT, software, clean tech and other technology companies in transactional matters, including public and private financings, licensing, collaborations and strategic alliances, and mergers and acquisitions. He also represents venture capital and investment banking firms in public and private financing transactions. He has represented companies and investors in over 100 venture capital and debt financing transactions, numerous public offerings, and dozens of public and private M&A transactions and strategic collaboration agreements.
Mr. Thau is a member of the Board of BayBio, Northern California’s leading life science association. He is a frequent speaker on venture capital financings and served on the faculty at the 2005 and 2007 Emerging Entrepreneurs workshops at Stanford University. Mr. Thau is recommended as a leading lawyer by PLC Which lawyer? 2011, Best Lawyers in America 2013, Chambers USA 2014, and Legal 500 US 2013 and 2014. He was named to the Daily Journal's inaugural list of 25 leading biotech lawyers in California, in 2011 and was recognized as a “Life Sciences Star” by LMG Life Sciences 2014.
Mr. Thau re-joined Morrison & Foerster in 2008 after having practiced corporate law for ten years at Venture Law Group and Heller Ehrman LLP. Mr. Thau began his legal practice as a litigator at Morrison & Foerster, focusing on securities and intellectual property. He also served as a law clerk to the Hon. Vaughn R. Walker in the United States District Court in the Northern District of California. He graduated Order of the Coif from Stanford Law School, where he was managing editor of the Stanford Law Review, and graduated magna cum laude from Harvard College in Biology.